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Abstract
Background: The literature did not evidence yet with which age spontaneously hypertensive rats (SHR) start to
present baroreflex reduction. We endeavored to evaluate the baroreflex function in eight-week-old SHR.
Methods: Male Wistar Kyoto (WKY) normotensive rats and SHR aged eight weeks were studied. Baroreflex was
calculated as the variation of heart rate (HR) divided by the mean arterial pressure (MAP) variation (ΔHR/ΔMAP)
tested with a depressor dose of sodium nitroprusside (SNP, 50 μg/kg) and with a pressor dose of phenylephrine
(PHE, 8 μg/kg) in the right femoral venous approach through an inserted cannula in the animals. Significant
differences for p < 0.05.
Results: Baseline MAP (p < 0.0001) and HR (p = 0.0028) was higher in SHR. Bradycardic peak was attenuated in
SHR (p < 0.0001), baroreflex gain tested with PHE was also reduced in the SHR group (p = 0.0012). PHE-induced
increase in MAP was increased in WKY compared to SHR (p = 0.039). Bradycardic reflex responses to intravenous
PHE was decreased in SHR (p < 0.0001).
Conclusion: Eight weeks old SHR already presents impairment of the parasympathetic component of baroreflex.
Introduction
Several factors (neural, humoral, myogenic) are involved
in the onset of hypertension and different animal mod-
els have been used to study this pathology, such as the
renal hypertension model, the DOCA-salt hypertension
model, the neurogenic hypertension model and the
genetic model of hypertension in spontaneously hyper-
tensive rats (SHR) [1]. SHR is a suitable model to study
hypertension development as it is similar to humans
with essential hypertension. These similarities include a
genetic predisposition to high blood pressure with no
specific etiology, increased total peripheral resistance
without volume expansion and similar responses to drug
treatment [1]. Moreover, cardiac hypertrophy, a stress
model of heart disease [2-4] is another feature of SHR
[5].
In cardiovascular physiology, the baroreflex or baror-
eceptor reflex is one of the body’sh o m e o s t a t i c
mechanisms to maintain blood pressure. It provides a
negative feedback loop in which the elevated blood
pressure reflexively causes blood pressure to decrease;
in contrast, the decreased blood pressure depresses the
baroreflex, causing blood pressure to rise. The system
relies on specialized neurons (baroreceptors) in the
aortic arch, carotid sinuses and elsewhere to monitor
changes in blood pressure and relay them to the brain-
stem. Subsequent changes in blood pressure are
mediated by the autonomic nervous system [6]. Pre-
vious studies related to the development of young SHR
baroreflex function have yielded conflicting results,
when compared to normotensive control rats (Wistar-
Kyoto - WKY) [7]. A study of Lundin et al [8] showed
that 15 weeks old present reduced baroreflex function.
Furthermore, a recent investigation evidenced that 13
weeks old SHR already present impaired baroceptor
reflex with respect to the parasympathetic component
[9]. A precise knowledge of early development damage
to the baroreflex function is essential to understand
hypertension as a disease process [10,11]. Therefore, in
this study we investigated cardiac baroreflex in eight
weeks old SHR. * Correspondence: luizcarlos@usp.br
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Animals
Eight weeks old SHR (n = 19) and WKY (n = 35) rats
were kept in the Animal Care Unit of our University.
We used higher number of WKY rats in order to have
trustful control values. Rats were housed individually in
plastic cages under standard laboratory conditions. They
were kept under a 12 h light/dark cycle (lights on at
07:00 h) and had free access to food and water. The
Institution’s Animal Ethics Committee authorized hous-
ing conditions and experimental procedures.
Surgical Preparation
One day before the experiments the rats were anesthe-
tized with ketamine (50 mg/kg i.p.) and xilazine (10 mg/
kg i.m.) and a catheter was inserted into the abdominal
aorta through the femoral artery for blood pressure and
heart rate recording. Catheters were made of 4 cm seg-
ments of PE-10 polyethylene (Clay Adams, USA) heat
bound to a 13 cm segment of PE-50 (Clay Adams,
USA). The catheters were tunneled under the skin and
exteriorized at the animal’s dorsum [9,12].
Arterial pressure and heart rate recording
After surgery, the animals were kept in individual cages
used in the transport to the recording room. Approxi-
mately 24 hours after the surgery, animals were allowed
20 min to adapt to the conditions of the experimental
room such as sound and illumination before starting
blood pressure and heart rate recording. The experi-
mental room was acoustically isolated and had constant
background noise produced by an air exhauster. At least
another 15 min period was allowed before beginning
experiments. Pulsatile arterial pressure (PAP) of freely
moving animals was recorded using an HP-7754A pre-
amplifier (Hewlett Packard, USA) and an acquisition
board (MP100A, Biopac Systems Inc, USA) connected
to a computer. Mean arterial pressure (MAP) and heart
rate (HR) values were derived from the PAP recordings
and processed on-line [9,12].
Baroreflex Test
The baroreflex was tested with a pressor dose of 0.1 mL
phenylephrine (PHE-bolus-8 μg/kg IV; Sigma Chemical)
and depressor doses of 0.1 mL sodium nitroprusside
(SNP-bolus-50 μg/kg IV; RBI) [9,12].
Baroreflex evaluation
The baroreflex gain was calculated as the derivation of
HR in function of the MAP variation (ΔHR/ΔMAP). We
also analyzed bradycardic and tachycardic peak and HR
range (the difference between bradycardic and tachycar-
dic peak) [9,12].
Statistical Analysis
Values are reported as the means ± standard error of
means. HR, MAP, ΔHR, ΔMAP and ΔHR/ΔMAP were
compared between WKY and SHR. After the
distributions were evaluated through the Kolmogorov
normality test, the unpaired Student’sTtest was used to
verify differences between normal distributions and the
Mann-Whitney test was used to assess differences
between non-parametric distributions. Differences were
considered significant when the probability of a Type I
error was less than 5% (p < 0.05).
Results
As shown in Table 1, we observed significant difference
between SHR and WKY control groups regarding base-
line MAP and HR. Furthermore, the values of bradycar-
dic peak in SHR were higher than WKY rats. Hence,
their bradycardic peak caused by MAP increase was
attenuated. Whereas tachycardic peak was significantly
increased in the same group, however, there was no sig-
nificant difference with respect to HR range. Baroreflex
gain tested with PHE was also significantly reduced in
the SHR group. On the other hand, we did not observed
significant alterations regarding baroreflex gain tested
with SNP.
PHE-induced increase in MAP was slightly but signifi-
cantly increased in WKY rats compared to the SHR
group (p = 0.039). Moreover, bradycardic reflex
responses to intravenous PHE was significantly
decreased in SHR (p < 0.0001) (Figure 1). Figure 2 pre-
sents representative recordings obtained during barore-
flex testing with PHE in conscious WKY and SHR,
showing expressive difference between WKY and SHR
groups in relation to PHE-induced increase in arterial
pressure. The reflex bradycardia in response to PHE was
significantly reduced in SHR.
Intravenous injections of SNP produced a vasodepres-
sor response, which was similar in both groups (p =
0.46). Moreover, tachycardic reflex in response to SNP-
induce decrease in MAP tended to be impaired in SHR
group but it did not reach statistical significance (p =
0.1) (Figure 3). We observe in Figure 4 representative
recordings obtained during baroreflex testing with SNP
Table 1 Baseline level of mean arterial pressure (MAP)
and heart rate (HR), bradycardic and tachycardic peak,
HR range and baroreflex gain (BG) in SHR (n = 19) and
WKY (n = 35) rats
Variable WKY SHR P Value
MAP (mmHg) 113.4 ± 1.66 162.89 ± 2.7 < 0.0001
HR (bpm) 313.34 ± 7.1 350 ± 8.9 0.0028
Bradycardic Peak (bpm) 242.5 ± 7.2 313.47 ± 9.4 < 0.0001
Tachycardic Peak (bpm) 444.56 ± 8.4 490 ± 9 0.0013
HR range (bpm) 198.03 ± 8.12 184.11 ± 13.35 0.3493
BG (bpm × mmHg
-1) PHE -1.3623 ± 0.1 -0.851 ± 0.09 0.0012
BG (bpm × mmHg
-1) NaNP -2.57 ± 0.18 -2.5 ± 0.26 0.837
Unpaired Student T test.
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Page 2 of 8Figure 1 Increase in mean arterial pressure (MAP, mmHg) and decrease in heart rate (HR, bpm) in response to phenylephrine (PHE, 8
μg/kg i.v.) in SHR (n = 19) and WKY (n = 35) rats. *p = 0.039;
#p < 0.0001: Different of SHR. Unpaired Student T test.
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sive difference between the groups. The tachycardic
reflex in response to SNP-induced decrease in arterial
pressure was similar in both groups.
Discussion
Our investigation was undertaken to evaluate barore-
flex function in eight weeks old SHR tested with SNP
and PHE and to verify whether there is any difference
between this study model and WKY rats at the same
age. Our findings demonstrate that at this age baseline
MAP and HR are already increased in SHR, which is
supported by the literature [9,13]. In addition, pressor
responses to PHE were increased in WKY whereas
bradycardic reflex was reduced in SHR. Bradycardic
peak, HR range and the parasympathetic component
of the baroreflex gain were attenuated in SHR. On the
other hand, no significant differences were noted in
relation to SNP-induced decrease in MAP, tachycardic
reflex and baroreflex gain tested with SNP.
The bradycardic peak is an index of maximal para-
sympathetic response to PHE-induced increase in blood
pressure; the tachycardic peak represents the maximal
sympathetic response to SNP-induced decrease in arter-
ial pressure; the HR range index represents the differ-
ence between the upper and lower HR peak and the
derivation of HR in function of MAP variation is an
index of baroreflex gain [14]. We reported that the max-
imal parasympathetic activity is already attenuated in
eight weeks old SHR compared to age-matched control
WKY rats. Our findings provide important evidence for
the recent hypothesis that young SHR already present
reduced parasympathetic function.
Our findings indicate no significant impairment of the
sympathetic component of baroreflex between eight
weeks old SHR and WKY rats at the same age. Great
attention has focused on the role of the sympathetic
activity regarding the onset of hypertension in SHR. Pre-
vious studies have shown that there is elevated sympa-
thetic drive to the vessels in adult SHR and have
suggested that this is relevant in the maintenance of
increased blood pressure [8,15]. It is possible that this
elevation in sympathetic output is not primarily a conse-
quence of changes in either baroceptor reflex [15] or
chemoreflex function but rather is a product of a modi-
fication of the central neural circuitry involved in
Figure 2 Recordings from one WKY and one SHR illustrating reflex bradycardia (top) in response to blood pressure increases. Infusions
were given in bolus. MAP, mean arterial pressure; PAP, pulsatile arterial pressure; HR, heart rate; PHE: phenylephrine.
Cisternas et al. International Archives of Medicine 2010, 3:2
http://www.intarchmed.com/content/3/1/2
Page 4 of 8Figure 3 Decrease in mean arterial pressure (MAP, mmHg) and decrease in heart rate (HR, bpm) in response to sodium nitroprusside
(SNP, 50 μg/kg i.v.) in SHR (n = 19) and WKY (n = 35) rats. Unpaired Student T test.
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above considerations, we expected the absence of differ-
ence between eight weeks old SHR and age-matched
WKY rats with respect to tachycardic peak, tachycardic
reflex and sympathetic baroreflex gain.
The mechanisms that cause the reduction of the bar-
oreflex function in SHR are not completely understood
[1]. Some studies investigated issues associated to affer-
ent limb, for example, one investigation demonstrated
that the carotid body in the adult SHR is significantly
larger than in normotensive rats [17,18], whereas other
studies indicated that the decreased baroreflex function
in SHR is due to impaired levels of norephinephrine,
epinephrine and dopamine in the carotid body [19,20].
Other researchers studied the central nervous system
[19-21]. It was evidenced that impaired levels of nore-
phinephrine, epinephrine and dopamine into the
medulla oblongata areas that regulate the cardiovascular
system [19-21] may be involved in baroreflex derange-
ment in SHR. Waki et al [22] have shown that endogen-
ous nitric oxide synthase activity in the medulla
oblongata of SHR is increased when compared to WKY;
it plays a major role in the preservation of the hyperten-
sion and decreases the cardiac baroreceptor reflex gain,
which are features of this animal model. Furthermore,
peripherical mechanisms are also associated to attenu-
ated baroreflex development in this strain, there have
been reports that AT1 (angiotensin) receptor densities
are increased in SHR, compared to the levels found in
normotensive control rats [23]. Rossi et al [23] indicated
that endogenous endothelin receptor mechanisms are
involved in the hypertensive state observed in SHR.
Moreover, recent investigations described the impor-
tance of oxidative stress [24] and the small GTPase rho-
quinase [25] during baroreflex function development in
SHR. Bertagnoli et al [24] suggested that exercise train-
ing reduces oxidative stress, which is associated to an
improvement in baroreflex sensitivity in SHR. Earlier
studies that described a significant difference in blood
pressure between WKY and SHR at 3 weeks of age [26]
or at birth [27] were based on the assessment of a few
animals. However, the age at which the baroreflex
Figure 4 Recordings from one control WKY and one SHR illustrating reflex tachycardia (top) in response to blood pressure decreases.
Infusions were given in bolus. MAP, mean arterial pressure; PAP, pulsatile arterial pressure; HR, heart rate; SNP: sodium nitroprusside.
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demonstrated.
PHE-induced increase in MAP was significantly
enhanced in WKY group compared to SHR group and
bradycardic reflex response to increase in arterial pres-
sure was also significantly increased in WKY rats. We
believe that PHE-induced increase in MAP was reduced
in SHR due their high blood pressure, which disable
them to present high variation of MAP. The reduced
bradycardic reflex response to increase in arterial pres-
sure in SHR is explained by their reduced parasympa-
thetic activity, which decrease the parasympathetic
component of baroreflex [7,16,28]. However, it is not
known yet with which age SHR begins to present preva-
lence of sympathetic activity. A recent study suggests
that the sympathetic activity starts to increase at new-
born stage [16]. On the other hand, no previous investi-
gation demonstrated when SHR begin to show
attenuated bradycardic reflex.
SNP-induced decrease in MAP and tachycardic reflex
was similar between WKY and SHR groups. Those para-
meters were used to calculate the sympathetic baroreflex
gain (baroreflex deactivation, ΔHR/ΔMAP). Thus, the
sympathetic baroreflex gain was also similar between
the both groups.
We report that SHR presented impairment of the
parasympathetic component of baroreflex function, asso-
ciated with preservation of sympathetic component. It is
well described that sympathetic activity is increased dur-
ing stress conditions [2-4,29] and SHR is also a model
to study hyperactivity and stress disorders [30,31]. The
imbalance between sympathetic and parasympathetic
components of the baroreflex in SHR is associated to
their sympathetic hyperactivity. Hence, this imbalance
collaborates to hypertension development in this strain
[24,25]. Our findings suggest that at eight weeks old this
discrepancy between sympathetic and parasympathetic
baroreflex gain in SHR probably cooperates to keep
increasing arterial pressure.
These data present relevant information, since cur-
rently baroceptor reflex is largely studied in different
models and strain of rats aiming to prevent hyperten-
sion development in human [9-11], due the fact that
reduced baroreflex function is indicative of cardiovascu-
lar disease [9,14,15]. We recognize the limitations of our
analysis in that we are unable to provide a full barore-
ceptor reflex function curve. However, the baroreflex
gain values obtained here are of physiological relevance,
because they fall around the operating point of this
reflex in an unrestrained conscious rat [12,25],
In conclusion, our investigation indicates that eight
weeks old SHR already presents impairment of the para-
sympathetic component of baroreflex function, while no
difference was observed regarding the sympathetic
component.
Acknowledgements
We thank Mr. Jason Saltsgiver for his critical evaluation of English Grammar.
This research was supported by grants from Fundação de Amparo à
Pesquisa do Estado de São Paulo (FAPESP).
Author details
1Department of Morphology and Physiology, School of Medicine of ABC, Av.
Príncipe de Gales, 821, Santo André 09060-650, Brazil.
2Department of
Clinical Medicine, Cardiology Division, School of Medicine of ABC, Av.
Príncipe de Gales, 821, Santo André 09060-650, Brazil.
3Department of
Medicine, Cardiology Division Federal University of São Paulo (UNIFESP), Rua
Napoleão de Barros, 715 Térreo, São Paulo 04039-032, Brazil.
4Department of
Physiology, Federal University of São Paulo (UNIFESP), Rua Napoleão de
Barros, 715 Térreo, São Paulo 04039-032, Brazil.
5Cardiovascular Surgery
Division, School of Medicine of ABC, Av. Príncipe de Gales, 821, Santo André
09060-650, Brazil.
6Speech Pathology and Audiology Department, Faculty of
Philosophy and Sciences, Paulista State University (UNESP), Av. Hygino Muzzi
Filho, 737, Campus Universitário, Marília 17525-900, Brazil.
Authors’ contributions
JRC, VEV, LCA, CF, NT, JRB, ACP and TBA performed the experimental
procedures and helped to write the manuscript. VEV, MP and LCA carried
out the statistical analysis and participated in design the manuscript. All
authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 30 September 2009
Accepted: 27 January 2010 Published: 27 January 2010
References
1. Frohlich ED: Hypertension 1986. Evaluation and treatment–why and how.
Postgrad Med 1986, 80:28-36.
2. Meneghini A, Ferreira C, Abreu LC, Ferreira M, Ferreira Filho C, Valenti VE,
Murad N: Cold stress effects on cardiomyocytes nuclear size in rats: light
microscopic evaluation. Rev Bras Cir Cardiovasc 2008, 23:530-3.
3. Meneghini A, Ferreira C, de Abreu LC, Valenti VE, Ferreira M, Filho CF,
Murad N: Memantine prevents cardiomyocytes nuclear size reduction in
the left ventricle of rats exposed to cold stress. Clinics 2009, 64:921-6.
4. Daud FV, Murad N, Meneghini A, Ferreira M, Ferreira Filho C, de Abreu LC,
Valenti VE, Ferreira C: Fluoxetine effects on mitochondrial ultrastructure
of right ventricle in rats exposed to cold stress. Rev Bras Cir Cardiovasc
2009, 24:173-9.
5. Lu JC, Cui W, Zhang HL, Liu F, Han M, Liu DM, Ying HN, Zhang K, Du J:
Additive beneficial effects of amlodipine and atorvastatin in reversing
advanced cardiac hypertrophy in elderly spontaneously hypertensive
rats. Clin Exp Pharmacol Physiol 2009, 36:1110-9.
6. Kirchheim HR: Systemic arterial baroreceptor reflexes. Physiol Rev 1976,
56:100-77.
7. Sato MA, Schoorlemmer GH, Menani JV, Lopes OU, Colombari E: Recovery
of high blood pressure after chronic lesions of the commissural NTS in
SHR. Hypertension 2003, 42:713-8.
8. Lundin S, Ricksten SE, Thoren P: Interaction between mental stress and
baroreceptor control of heart rate and sympathetic activity in conscious
spontaneously hypertensive (SHR) and normotensive (WKY) rats. J
Hypertens Suppl 1983, 1:68-70.
9. Valenti VE, Ferreira C, Meneghini A, Ferreira M, Murad N, Ferreira Filho C,
Correa JA, de Abreu LC, Colombari E: Evaluation of baroreflex function in
young spontaneously hypertensive rats. Arq Bras Cardiol 2009, 92:205-9.
10. Adami M, Nardin M, Morello E, Crivellaro C, Wiedermann CJ: Fatal cardiac
arrest in an adult patient with euthyroid anti-SSA/Ro-positive connective
tissue disease: a case report. Int Arch Med 2009, 2:15.
11. Shehata MF: Characterization of the epithelial sodium channel alpha
subunit coding and non-coding transcripts and their corresponding
Cisternas et al. International Archives of Medicine 2010, 3:2
http://www.intarchmed.com/content/3/1/2
Page 7 of 8mRNA expression levels in Dahl R versus S rat kidney cortex on normal
and high salt diet. Int Arch Med 2009, 2:5.
12. Valenti VE, Imaizumi C, de Abreu LC, Colombari E, Sato MA, Ferreira C:
Intra-strain variations of baroreflex sensitivity in young Wistar-Kyoto rats.
Clin Invest Med 2009, 32:E251.
13. Simms AE, Paton JF, Pickering AE, Allen AM: Amplified respiratory-
sympathetic coupling in the spontaneously hypertensive rat: does it
contribute to hypertension?. J Physiol 2009, 587:597-610.
14. Head GA, McCarty R: Vagal and sympathetic components of the heart
rate range and gain of the baroreceptor-heart rate reflex in conscious
rats. J Auton Nerv Syst 1987, 21:203-213.
15. Judy WV, Watanabe AM, Henry DP, Besch HR Jr, Murphy WR, Hockel GM:
Sympathetic nerve activity: role in regulation of blood pressure in the
spontaenously hypertensive rat. Circ Res 1976, 38:21-9.
16. Grisk O, Exner J, Schmidt M, Honig A: Effects of acute hypoxia and
hyperoxia on ventilation in spontaneously hypertensive and
normotensive rat. J Auton Nerv Syst 1996, 57:177-180.
17. Habeck JO, Honig A, Pfeiffer C, Schmidt M: The carotid bodies in
spontaneously hypertensive (SHR) and normotensive rats-a study
concerning size, location and blood supply. Anat Anz 1981, 150:374-84.
18. Pallot DJ, Barer GR: Some observations on the carotid bodies of the New
Zealand strain of genetically hypertensive rats. Acta Physiol Pol 1985,
36:65-75.
19. Alho H, Koistinaho J, Kovanen V, Suominen H, Hervonen A: Effect of
prolonged physical training on the histochemically demonstrable
catecholamines in the sympathetic neurons, the adrenal gland and
extra-adrenal catecholamine storing cells of the rat. J Auton Nerv Syst
1984, 10:181-91.
20. Przybylski M, Tripiana J, Gattelet P: Results of an experiment-from unity to
division (and back again). Krankenpfl Soins Infirm 1990, 83:55-60.
21. Morrison SF, Whitehorn D: Baroreceptor reflex gain is not diminished in
spontaneous hypertension. Am J Physiol 1982, 243:R500-5.
22. Waki H, Murphy D, Yao ST, Kasparov S, Paton JF: Endothelial NO synthase
activity in nucleus tractus solitarii contributes to hypertension in
spontaneously hypertensive rats. Hypertension 2006, 48:644-50.
23. Veerasingham SJ, Raizada MK: Brain renin-angiotensin system dysfunction
in hypertension: recent advances and perspectives. Br J Pharmacol 2003,
139:191-202.
24. Rossi NF, O’Leary DS, Woodbury D, Chen H: Endothelin-1 in hypertension
in the baroreflex-intact SHR: a role independent from vasopressin
release. Am J Physiol Endocrinol Metab 2000, 279:E18-24.
25. Bertagnolli M, Campos C, Schenkel PC, de Oliveira VL, De Angelis K, Belló-
Klein A, Rigatto K, Irigoyen MC: Baroreflex sensitivity improvement is
associated with decreased oxidative stress in trained spontaneously
hypertensive rat. J Hypertens 2006, 24:2437-43.
26. Lais LT, Rios LL, Boutelle S, DiBona GF, Brody MJ: Arterial pressure
development in neonatal and young spontaneously hypertensive rats.
Blood Vessels 1977, 14:277-84.
27. Gonzalez ER, Krieger AJ, Sapru HN: Central resetting of baroreflex in the
spontaneously hypertensive rat. Hypertension 1983, 5:346-52.
28. Judy WV, Farrell SK: Arterial baroreceptor reflex control of sympathetic
nerve activity in the spontaneously hypertensive rat. Hypertension 1979,
1:605-14.
29. Ferreira M, Ferreira C, de Abreu LC, Valenti VE, Murad N, Meneghini A,
Filho CF, Filho JA: Myocardium tissue changes caused by electrical
transthoracic discharges in rats. Int Arch Med 2009, 2:31.
30. Vendruscolo LF, Izídio GS, Takahashi RN: Drug reinforcement in a rat
model of attention deficit/hyperactivity disorder–the Spontaneously
Hypertensive Rat (SHR). Curr Drug Abuse Rev 2009, 2:177-83.
31. Russell VA: Neurobiology of animal models of attention-deficit
hyperactivity disorder. J Neurosci Methods 2007, 161:185-98.
doi:10.1186/1755-7682-3-2
Cite this article as: Cisternas et al.: Cardiac baroreflex is already blunted
in eight weeks old spontaneously hypertensive rats. International
Archives of Medicine 2010 3:2.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Cisternas et al. International Archives of Medicine 2010, 3:2
http://www.intarchmed.com/content/3/1/2
Page 8 of 8